SonoScape Medical Corp (300633)
Shenzhen Stock Exchange · China · prices in CNY · close of 23 Oct 2026
Key indicators
| Last close | CNY 21.24 |
|---|---|
| 52-week range | 17.20 – 34.45 |
| Return, 1 month / 3 months | +7.5% / +13.2% |
| Return, 1 year / 3 years | −34.8% / −52.5% |
| Trend | Below its 200-day average |
| RSI (14) | 63 |
| Volatility (1 year) | 34.8% |
| Worst drawdown (1 year) | -48.3% |
| Average daily value traded | 97.42M CNY |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SonoScape Medical Corp designs and makes medical imaging and endoscopic equipment. Its product range covers ultrasound systems, including colour Doppler machines, and flexible endoscopes used for examination and minimally invasive procedures. Hospitals, clinics and healthcare providers are the main customers, and the company serves both domestic and overseas medical markets. SonoScape is based in Shenzhen, China, where it develops and manufactures its imaging devices.
SonoScape Medical Corp trades under the code 300633 on the Shenzhen Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SonoScape Medical Corp (300633) trades on the Shenzhen Stock Exchange in China. It last closed at CNY 21.24 on 23 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,374 of 2,821 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.8% and over the last three months it rose 13.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shenzhen Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -6.5% | ||
| From 52-week high | -37.8% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 13.2% | ||
| 6-month return | -22.4% | ||
| 12-month return, skipping the last month | -39.4% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.3% | ||
| Liquidity | 40 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 97.42M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +13.5% |
|---|---|
| 1 month | +7.5% |
| 3 months | +13.2% |
| 6 months | −22.4% |
| 1 year | −34.8% |
| 3 years | −52.5% |
| 5 years | −38.1% |
Signals
| 50-day / 200-day average | 19.72 / 22.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.92 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Jun 2026 | CNY 0.1800 |
| 29 May 2025 | CNY 0.1000 |
| 29 May 2024 | CNY 0.3200 |
| 8 Jun 2023 | CNY 0.1800 |
| 15 Jul 2022 | CNY 0.1250 |
| 10 Jul 2020 | CNY 0.0260 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shenzhen Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.